Cellular Immunotherapy for Patients With High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia
Clinical trial NCT03083054 · UNKNOWN
Trial details
- NCT number
- NCT03083054
- Sponsor
- University of Campinas, Brazil
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2020-07-12
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.